P. Selvakumar
Research Subjects
Research Interests
P. Selvakumar has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
D. Satheesh Kumar
1 shared publicationG. Satheesh Kumar
1 shared publicationNavneet Sharma
1 shared publicationR. Sivanand
1 shared publicationT. C. Manjunath
1 shared publicationTaruna Anand
1 shared publication
Latest Publications
- Open Access
- 10 July 2025
- Published by Journal of Environmental Nanotechnology in Journal of Environmental Nanotechnology
- Vol. 14 (2) , 458-470
Nanotechnology Applications in Cancer Drug Delivery Systems: A Review
Nanotechnology of medicine, particularly therapy, by novel longstanding in drug delivery. Cancer, a complex and multifaceted disease, demands innovative therapeutic approaches capable of addressing its heterogeneity, drug resistance, and adverse effects associated with conventional avenues for nanomaterials, dimensions, large-to-volume ratio, and the ability to be functionalized for specific purposes. Moreover, advancements in nanotechnology have enabled chemotherapeutics, siRNA, to address the multifactorial nature of cancer and overcome drug resistance mechanisms. Advancements, nanotechnology significant challenges. Issues such as scalability in manufacturing, reproducibility, and biocompatibility, hinder cancer and further complicate the design of universally effective nanocarriers, necessitating tailored approaches for different cancer types and patient populations. This review examines the developments driven by cancer highlighting design principles and their impact on improving therapeutic outcomes. It also offers insights into emerging trends and future directions. With continuous innovation and interdisciplinary collaboration, nanotechnology holds immense potential to transform cancer therapy, and targeted, patient-specific treatment modalities.
- 10 July 2025
- Published by Journal of Environmental Nanotechnology in Journal of Environmental Nanotechnology
- Vol. 14 (2) , 458-470
Open AccessNanotechnology Applications in Cancer Drug Delivery Systems: A Review
Nanotechnology of medicine, particularly therapy, by novel longstanding in drug delivery. Cancer, a complex and multifaceted disease, demands innovative therapeutic approaches capable of addressing its heterogeneity, drug resistance, and adverse effects associated with conventional avenues for nanomaterials, dimensions, large-to-volume ratio, and the ability to be functionalized for specific purposes. Moreover, advancements in nanotechnology have enabled chemotherapeutics, siRNA, to address the multifactorial nature of cancer and overcome drug resistance mechanisms. Advancements, nanotechnology significant challenges. Issues such as scalability in manufacturing, reproducibility, and biocompatibility, hinder cancer and further complicate the design of universally effective nanocarriers, necessitating tailored approaches for different cancer types and patient populations. This review examines the developments driven by cancer highlighting design principles and their impact on improving therapeutic outcomes. It also offers insights into emerging trends and future directions. With continuous innovation and interdisciplinary collaboration, nanotechnology holds immense potential to transform cancer therapy, and targeted, patient-specific treatment modalities.
- Open Access
- 18 April 2025
- Published by Journal of Environmental Nanotechnology in Journal of Environmental Nanotechnology
- Vol. 14 (1) , 453-463
Reducing the Carbon Footprint in Healthcare
The medical industry produces enormous waste, including single-use plastics, hazardous materials, and organic waste. According to estimates, hospitals generate approximately 29 pounds of waste per patient daily, much of which is not environmentally sustainable. Disposing this waste often involves incineration or landfilling, contributing to greenhouse gas emissions. Implementing more sustainable waste management practices, such as recycling and composting, can mitigate this impact and lead to a more circular economy within the healthcare sector. Transportation also contributes significantly to the carbon footprint of healthcare. It includes the emissions from transporting patients to medical facilities and the logistics of delivering medical supplies and pharmaceuticals. The rise of telemedicine could reduce some of these emissions by minimizing the need for travel. Still, it is also essential to consider the energy consumption associated with digital infrastructure. Several initiatives are underway globally to promote sustainability in healthcare. Organizations increasingly commit to reducing their carbon footprints through pledges, frameworks, and accreditation systems that recognize sustainable practices. For example, the Health Care Climate Challenge encourages healthcare organizations to take action to reduce emissions and improve climate resilience. Additionally, many countries are integrating sustainability into their healthcare policies, recognizing the importance of a healthy planet for the well-being of their populations. In conclusion, understanding the carbon footprint of healthcare is vital for addressing the dual challenges of climate change and public health.
- 18 April 2025
- Published by Journal of Environmental Nanotechnology in Journal of Environmental Nanotechnology
- Vol. 14 (1) , 453-463
Open AccessReducing the Carbon Footprint in Healthcare
The medical industry produces enormous waste, including single-use plastics, hazardous materials, and organic waste. According to estimates, hospitals generate approximately 29 pounds of waste per patient daily, much of which is not environmentally sustainable. Disposing this waste often involves incineration or landfilling, contributing to greenhouse gas emissions. Implementing more sustainable waste management practices, such as recycling and composting, can mitigate this impact and lead to a more circular economy within the healthcare sector. Transportation also contributes significantly to the carbon footprint of healthcare. It includes the emissions from transporting patients to medical facilities and the logistics of delivering medical supplies and pharmaceuticals. The rise of telemedicine could reduce some of these emissions by minimizing the need for travel. Still, it is also essential to consider the energy consumption associated with digital infrastructure. Several initiatives are underway globally to promote sustainability in healthcare. Organizations increasingly commit to reducing their carbon footprints through pledges, frameworks, and accreditation systems that recognize sustainable practices. For example, the Health Care Climate Challenge encourages healthcare organizations to take action to reduce emissions and improve climate resilience. Additionally, many countries are integrating sustainability into their healthcare policies, recognizing the importance of a healthy planet for the well-being of their populations. In conclusion, understanding the carbon footprint of healthcare is vital for addressing the dual challenges of climate change and public health.
- Open Access
- 1 August 2024
- Published by An-Najah National University in Palestinian Medical and Pharmaceutical Journal
- Vol. 9 (3) , 306-322
Anti-Diabetic Potential of Therapeutic Medicinal Plants: A Review
Drugs for diabetes are incredibly effective, but they also have serious adverse effects. Therapeutic plants, on the other hand, might function as an alternative source of antidiabetic mediators. With an emphasis on preclinical and scientific studies, therapeutic florae with antidiabetic potential are recognized. The mutual and concentrated act of their profile of organically energetic natural complexes defines the valuable probability of each specific plant condition. Due to its all-natural origins and absence of concomitant side effects, herbal medicine has become exponentially more appealing in recent years, gaining fame in both emerging and developed nations. A systematic education program was put in place to gather data on medicinal plants that are used to treat diabetes mellitus. The descriptions are in charge of providing details on the scientific and family names of the plants, plant parts, and research prototypes used. The enormous number of plants identified in this study demonstrated the importance of herbal plants in the prevention of diabetes. The characteristics of these herbs can help delay the onset of metabolic discrepancies and diabetes complications. This study motivates researchers to make additional changes to the upcoming utilization of medicinal plants with anti-diabetic properties.
- 1 August 2024
- Published by An-Najah National University in Palestinian Medical and Pharmaceutical Journal
- Vol. 9 (3) , 306-322
Open AccessAnti-Diabetic Potential of Therapeutic Medicinal Plants: A Review
Drugs for diabetes are incredibly effective, but they also have serious adverse effects. Therapeutic plants, on the other hand, might function as an alternative source of antidiabetic mediators. With an emphasis on preclinical and scientific studies, therapeutic florae with antidiabetic potential are recognized. The mutual and concentrated act of their profile of organically energetic natural complexes defines the valuable probability of each specific plant condition. Due to its all-natural origins and absence of concomitant side effects, herbal medicine has become exponentially more appealing in recent years, gaining fame in both emerging and developed nations. A systematic education program was put in place to gather data on medicinal plants that are used to treat diabetes mellitus. The descriptions are in charge of providing details on the scientific and family names of the plants, plant parts, and research prototypes used. The enormous number of plants identified in this study demonstrated the importance of herbal plants in the prevention of diabetes. The characteristics of these herbs can help delay the onset of metabolic discrepancies and diabetes complications. This study motivates researchers to make additional changes to the upcoming utilization of medicinal plants with anti-diabetic properties.
- Open Access
- 11 December 2023
- Published by Institute of Molecular Biology and Genetics (NAS Ukraine) in Biopolymers and Cell
- Vol. 39 (4) , 245-256
Biomedical applications of polymers in biosensors, cancer vaccines and drug delivery systems
Aim. To analyze the substantial development of biomedical polymers in a number of potential biomedical domains, including the disease diagnosis and therapy. Results. The relationship between material's properties and functions for matching biomedical applications is thoroughly elucidated in this paper, along with a rundown of current advancements in the production and appliance of biomedical polymers. The peptide, biomembrane, microbe and cell-based biomedical polymers are presented and highlighted as new biomaterials for the tumor precision treatment. Additionally, the prospects and difficulties of creating the future biomedical polymers, which are healthier, safer, and more effective, are appraised. Conclusions. This systematic and in-depth analysis of the most recent advancements in the biomedical polymers development is intended to inspire and promote new discoveries in the basic science and clinical application. K e y w o r d s: biomedical polymers
- 11 December 2023
- Published by Institute of Molecular Biology and Genetics (NAS Ukraine) in Biopolymers and Cell
- Vol. 39 (4) , 245-256
Open AccessBiomedical applications of polymers in biosensors, cancer vaccines and drug delivery systems
Aim. To analyze the substantial development of biomedical polymers in a number of potential biomedical domains, including the disease diagnosis and therapy. Results. The relationship between material's properties and functions for matching biomedical applications is thoroughly elucidated in this paper, along with a rundown of current advancements in the production and appliance of biomedical polymers. The peptide, biomembrane, microbe and cell-based biomedical polymers are presented and highlighted as new biomaterials for the tumor precision treatment. Additionally, the prospects and difficulties of creating the future biomedical polymers, which are healthier, safer, and more effective, are appraised. Conclusions. This systematic and in-depth analysis of the most recent advancements in the biomedical polymers development is intended to inspire and promote new discoveries in the basic science and clinical application. K e y w o r d s: biomedical polymers